Revenue
No reported data
Medicus Pharma Ltd. (MDCX)
Price—Loading quote
Net income
2023
2024
2025
Free cash flow
No reported data
Total cash / debt
CashTotal debt
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Research & development | $8.7M | $0 | $193,578 |
| Operating expenses | $34.4M | $11.2M | $4.7M |
| Operating income | −$34.4M | −$11.2M | −$4.7M |
| Net income | −$47.3M | −$11.2M | −$5.3M |
| Basic EPSper diluted share | -$2.74 | -$1.16 | -$1.53 |
| Diluted EPSper diluted share | -$2.74 | -$1.16 | -$1.53 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 20, 2025Form 4 | Melani Kenneth R. +1TenPercentOwner | SellMedicus Pharma LTD · indirect | 75.0K | $7.72 | $579.0K | 3.25M |